STAT+: White House looks for more drug pricing deals to add to TrumpRx
Stat News • 2/6/2026
Summary
The Trump administration is seeking additional companies to provide prescription drugs at discounted cash prices on TrumpRx.
Advertisement
Lindy Score Breakdown (V4.2)
56d
Age
1
Sources
from cluster
1350
Hours Since Seen
Final Score0/100
CategoryAntiLindy
StatusArchived
Recency Multiplier0% (0.5^1350/48)
Hero EligibleNo
Score is 0 because recency decay (0.5^1350/48 = 0.000000) reduced it below 0.5
Score BreakdownRisk 50
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: 56 days - proven survivor
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
STAT+: Small drugmakers, facing threat of tariffs, negotiate pricing deals with White House
Stat News • 1 day ago
STAT+: White House proposes 12% cut to federal health agencies in 2027 budget request
Stat News • Today
STAT+: Pharmalittle: We’re reading about Trump’s drug tariffs, a U.S.-U.K. pharma trade deal, and more
Stat News • Today
STAT+: Insilico Medicine CEO on how best to use AI in drug development
Stat News • 2 days ago
STAT+: Government watchdog urges FDA to finalize guidance for advisory committee conflicts of interest
Stat News • 2 days ago
STAT+: Beyond detection: In the age of clinical AI, what counts as an FDA ‘breakthrough’ medical device?
Stat News • 1 day ago
STAT+: Pharmalittle: We’re reading about Trump tariff plans, FDA’s OK for a Lilly obesity pill, and more
Stat News • 1 day ago
Opinion: Subscription pricing could expand access to HIV prevention breakthrough while controlling costs
Stat News • Today
STAT+: Medicare Advantage plans win extra $18.6 billion as feds cut star ratings measures
Stat News • 1 day ago
STAT+: Up and down the ladder: The latest comings and goings
Stat News • Today
Anti-Lindy Similar stories
STAT+: Pharmalittle: We’re reading about Trump pushing drug pricing policy, Chinese biotech licensing, and more
Stat News • 4 days ago
STAT+: FDA approves Denali Therapeutics drug for Hunter syndrome
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about an FDA OK for a rare disease drug, a grilling of the PTO chief, and more
Stat News • 1 week ago
STAT+: Merck to buy Terns Pharmaceuticals in $6.7B deal
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about a Merck acquisition, the rise of former Loxo execs at Lilly, and more
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about pharma delaying launches in Europe, Lilly and Biogen deals, and more
Stat News • 3 days ago